Below is an article that appeared in The New
England Journal of Medicine, vol 326 dated March 12 1992.
BY: George J Annas, JD.,MPH
Shortly before the beginning of Operation Desert Storm, during
Desert Shield, the US military sought a waiver of requirements
for informed consent for the use of investigational drugs and
vaccines on our troops in the Persian Gulf. The danger of
chemical and biological warfare was seen as demanding this
waiver, although the Nuremberg Code, other codes of medical
ethics and respect for the human rights American soldiers seemed
to caution against it. One year later it seems reasonable to
review this decision. The legal manouvering to revise consent
regulations for wartime conditions provides a case study that
highlights three separable issues: how easily the line between
therapy and experimentation can become blurred; the differences
between law and ethics; and the ethical obligations of physicians
when interests of their patients conflict with the interests of
their employer.
The Nuremberg Code & The US Army
The Nuremberg code was promulgated by the US judges sitting under
the authority of the US Army at Nuremberg, Germany, in 19471,2
The defendants in the Doctors trial were charged with war crimes
and crimes against humanity for performing both lethal and none
lethal experiments on prisoners. Most were found guilty, and
seven were hanged. The judges also set forth the Nuremberg Code,
a ten point declaration governing human experimentation that was
based on "principles of the law of nations as they result from
the usages established among civilised peoples, from the laws of
humanity, and from the best dictates of public conscience."1 The
first and best known principle provides that voluntary,
competent, informed, and understanding consent of the subject is
"absolutely essential." There is no exception for soldiers or for
wartime, and until Desert Shield, the US Army had never argued
that there should be such an exception. Current US statutory law
also requires that informed consent be obtained for all
"investigational use" of drugs, except when the investigators
consider it "not feasible, or in their professional judgement,
contrary to the best interests of such human beings."3
In the fall of 1990, after the invasion of Kuwait by Iraq,
the Department of Defense (DoD) sought a waiver of the consent
requirements in the Food & Drug Administration's existing
regulations governing human experimentation so that the military
could administer investigational drugs and vaccines to the Desert
Shield soldiers without their informed consent. The justification
for the request was military expediency. In the words of the D0D
request: "In all peace time applications, we believe strongly in
informed consent and it's ethical foundations....but military
combat is different."4 The department argued that informed
consent under combat conditions was "not feasible" because some
troops might refuse to consent, and the military could not
tolerate such refusals because of "military combat exigencies."4
The FDA granted the request and issued a new general regulation,
rule 23(d)5 that permits waivers on a drug by drug basis on the
grounds that consent is "not feasible in a specific military
operation involving combat or the immediate threat of combat."4
Shortly after the new regulation was promulgated, and just
before Desert Storm, a suit was brought by the Public Citizen
Health Research Group on behalf of an unnamed soldier (John Doe)
and his wife to enjoin the DoD from using drugs on troops in the
Persian Gulf without consent, on the basis of rule 23(d). At that
time, the FDA had granted under rule 23(d) for the use of two
agents, pyridostigmine bromide (30mg tablets, for use as a pre
treatment for nerve gas attacks) and pentavalent botulinum-toxoid
vaccine (to protect against botulism in biological warfare).
The Decision of The District Court
US District Court Judge Stanley Harris made it clear that he had
no desire to become involved in military matters. In his
words,"The (DoD's) decision to use unapproved drugs is precisely
the type of military decision that courts have repeatedly refused
to second guess."6 He characterised the decision as one intended
to protect individual servicemen and women, and as "strategic" in
nature and thus not subject to review by a court. He went on,
however, to say that if he thought he had the authority to review
the decision, he would uphold it.
Consistent with the Nuremberg Code, the DoD's Authorization
Act prohibits the prohibits the DoD from using any of its funds
"for any research involving a human being as an experimental
subject" unless the subject's informed consent has been
obtained.7 This restriction was enacted in response to US Army
experiments at the beginning of the Cold War in which servicemen
were exposed to radiation or given lysergic acid diethylamide
(LSD).2 Judge Harris, however, decided that "the primary purpose
of administering the drugs is military, not scientific," and
therefore that statutory prohibition was inapplicable.6
The "not feasible" exception to the consent requirement had
previously been applied only to subjects who were unable to
communicate, unconscious, or incompetent. Nonetheless, Judge
Harris decided that the FDA could reinterpret this exception as
long as its interpretation was not "arbitrary, capricious or
manifestly contrary to the statute."6 Finally, he rejected the
claim that forced administration of unapproved drugs violates the
Fifth amendment interests of servicepersons in not being
experimented on without their consent. Instead, he found that the
military's interest in preventing injury to troops and
"successfully accomplishing the military goals of Operation
Desert Storm" were sufficient to justify the exception to the
regulations on informed consent. The Nuremberg Code was not
mentioned in the decision.
The Decision of The Court of Appeals
"John Doe" appealed. At the hearing, held in March 1991, a letter
was introduced from the DoD to the FDA saying that the military
requirements for the use of the two agents without informed
consent had ended. The department also informed the FDA that
"Central Command has recently reported that the military command
in the theatre of operations decided to administer the vaccine on
a voluntary basis. The pyridostigmine tablets were used without
prior informed consent." The Justice department argued that
because of the end of the war and the DoD's letter. the case was
moot and should be dismissed by the US Circuit Court of Appeals.
The majority of the court, in a two to one option written by
Judge Ruth Ginsburg in July, disagreed.7 The court concluded that
even though the DoD had withdrawn its two specific waivers, rule
23(d) remained in effect and the situation could therefor arise
again. The court relied heavily on government reports concerning
the proliferation of nuclear, chemical, and biological weapons
systems, especially among Third World nations such as Iraq.
On
the merits, the Court of Appeal disagreed with the lower court
that the case was beyond the scope of court review because it was
military in nature. Instead the court defined the issue as a
challenge to the FDA's authority to issue a waiver of its consent
regulations to the DoD, not as an action challenging military
decisions. The Court of Appeals did, however, agree with all the
other conclusions of the lower court. Again no mention was made
of the Nuremberg Code.8
Judge Clarence Thomas, then a member for the appeals court,
filed a dissenting opinion. He agreed with the Justice
Department, arguing that because the war was over and because it
was virtually impossible for John doe to be subjected to the rule
again, the case should be dismissed as moot. He said that the
majority "surely overstates" the risk of future chemical warfare,
noting that "after all, American soldiers have not been victims
of organized chemical attack since the First World War."8 Judge
Thomas also stressed that there was no "reasonable likelihood
that John Doe, personally" would be involved in any future war
involving chemical weapons. In his words, "the majority focuses
on rule 23(d) in the abstract - and in the process forgets about
John Doe, the plaintiff."8
Ironically, all Judge Thomas' arguments support the
proposition that the rule should never have been promulgated in
the first place: the risk of chemical and biological warfare in
the Gulf seems to have been overstated. and the proper concern
should focus on individual soldiers, whom the military (and the
FDA) had succeeded in treating as merely the means to accomplish
a mission.
The Implications of The Decisions
Since the time of Cicero, it has been said that inter arma
silentae sunt - amid the clash of arms the laws are silent. This
was certainly true during the forced internment of Japanese -
Americans from the west coast during World War Two,9 and it was
true of the courts in this recent case as well. While troops are
in the field, courts are unlikely to make any decisions that
appear to be intefearning with the military. This evidence of
realpolitik is disturbing, but not surprising. The brief history
of International human rights has, after all, been written
primarily in the aftermath of war; the founding of the UN in
1946, the International declaration of Human Rights in 1948, and
current efforts to foster human rights in the wake of the Cold
War. Neither of the courts in the Doe case was likely to discuss
the Nuremberg Code because the waiver rule is a clear violation
of it, and acknowledging this violation could have embarrassed
the United States. We might have appeared hypocritical because at
the time these cases were heard, members of the administration
were calling for a Nuremberg - style tribunal to try Saddam
Hussein and his military leaders for violations of international
law. International human rights laws must, of course, apply to
both victors and vanquished.
Even though rule 23(d) authorizes the violation of the
Nurmeberg Code, it can be argued persuasively that the code
itself was not actually violated during Operation Desert Storm.
According to this argument, the code only applies to
experimentation or research on human beings, and the DoD was not
conducting research. this was not, after all, anything like the
Army's secret experiments with radiation or LSD in the 1950's and
1960's.2 What was at stake in the case of pyridostigmine bromide
tablets was the use of an approved drug for an unapproved reason.
Such use can be justified in certain circumstances and could even
be considered treatment if nerve gas attack appeared imminent, as
it did to the commander of XVIII Airborne Corps whose 41,650
soldiers took the drug for one to seven days at eight hour
intervals.10
Members of the military have no right to refuse any medical
treatment that can make them fit for combat or return them to
active duty. The reason it is legally acceptable to require
combat troops to be treated if treatment can return them to
active duty is that it would be impossible to have an effective
armed force if refusal could be used as a way to avoid combat or
other risky assignments. The distinction between treatment and
experimentation (or research) may seem arbitrary - and at the
margin. it often is - but it is based on the following rationale.
Treatment is given for the benefit of the individual patient,
rather than for the benefit of society or a researcher, and when
sufficient data are available to determine whether the
intervention is likely to be helpful or harmful to that patient.
Historically, "nontherapeutic experimentation" on healthy
volunteers has been the model for research, whereas "therapeutic
experimentation" on patients is more and more seen simply as
therapy. Thus, if pyridostigmine is a treatment, requiring its
use does not violate the Nuremberg Code.11,12
I think this argument is correct, even though data from
Desert Storm were collected and analyzed,10 and that it was
unnecessary for the DoD to ask for a waiver of the requirement
for informed consent by research subjects to administer this
agent. The Court of Appeals should have used this rationale for
its decision. The Army, Navy and Air Force seem also to have
agreed with this view, since they were prepared to dispense
pyridostigmine to troops long before the waiver was even
sought.13
It is much more difficult, however, to make the same
argument for botulinum toxoid vaccine. This vaccine has been used
by about 3000 laboratory workers in the past, but its use was
discontinued in the mid 1970's (before sufficient data on safety
and efficacy had been gathered to qualify it for licensure) and
few laboratory workers have used it since. It remains an
unapproved agent. and the Centres for Disease Control have an
elaborate consent form that explains its experimental nature as
an investigational new drug. The reason that the military did not
violate the Nuremberg Code in giving this vaccine to troops is
not that it can be legitimately considered treatment or therapy,
but it was decided to give the troops in the Persian Gulf the
right to refuse to be vaccinated. This decision merits
commendation, and it would be interesting to know more about how
and why military commanders in the field chose not to take
advantage of their legal authority to give this vaccine to the
troops without consent. No matter what their motivation, however,
I do believe that they were correct. They may indeed have taken
the principles of the Nuremberg Code more seriously than did the
DoD or the FDA, or the two courts in the case.
As the Court of Appeals noted, the DOD had argued in court
that these agents had not previously been tested in controlled
clinical trials "because humans cannot intentionally be exposed
to chemical or biological (warfare) agents in order to test the
efectivness of a drug."8 This is true primarily because such
exposure violates another dictate of the Nuremberg Code; "No
experimentation should be conducted where there is a prior reason
to believe that death or disabling injury will occur."14 General
Norman Schwarzkopf and his medical command seem to have
understood that one cannot pick and choose which items of the
Nuremberg Code to take seriously.
The Role of Military Physicians
What should physicians in the military do when asked to
administer investigational agents without the informed consent of
the soldiers ? Even if such administration is legal (as the
courts have ruled), many would find it unethical, and as the
Nuremberg trials affirmed, "following orders" is no excuse for
unethical conduct, even in combat. The only justification a
physician could have for participating in the administration of
experimental or investigational agents without soldiers consent
is that he or she sincerely believes the agents are therapeutic
under combat conditions. This is, of course, a difficult position
to take, since war does not change the nature of a drug or
vaccine. Such a decision would also be contrary to military
regulations, which hold that, although a serviceperson must
accept standard medical treatment or face court martial, soldiers
have no obligation to accept interventions that are not generally
recognized by the medical profession as standard procedures.14,15
A related question is a whether military physician is
primarily responsible for the health and well being of the
soldiers under his or her care (as in civilian life) or whether
he or she must subordinate the medical interests of soldier -
patients to the military mission. Remarkably, there is no written
policy or standard view on this question in the military. The
issue deserves critical attention in peacetime, since it is not
susceptible to rational analysis in wartime. An unequivocal
policy upholding traditional patient - centred ethics, although
not legally required, seems the most responsible position for US
military physicians who do not serve in combat situations to
take.
The experience with rule 23(d) during Operation Desert Storm
illustrates the difficulty of making distinctions between
experimental interventions and treatment, the difference between
law (especially as enunciated by the courts during wartime) and
ethics,and the potential conflicts between the best interests of
a physicians patients and the interests of a physicians employer.
Although it was designed to resolve these conflicts, rule 23(d)
primarily served to highlight them, and to reverse a 44 year old
policy of following the Nuremberg Code. The rule not only turned
out to be militarily unnecessary but also called into question
the seriousness of the United States' human rights agenda.
1. Trials of war criminals before the Nuremberg Military
Tribunals. Tribunal 1 case 1. The military case: United States of
America v Karl Brandt et al. Vol 2, Washington DC; Government
Printing Office 1950 2. The Nazi doctors and the Nuremberg Codes, human rights in
experimentation, New York , Oxford University Press 1992; 61-
129,188-208
3. 21 USC sec 355(1)
4. Informed consent for human drugs and biologies;
determination that informed consent is not feasible. Fed
Regs,1990; 35-52,814-7
5. 21 CPR sec 50.25(d) 6. Doe v Sullivan, 756F supp 12 (DDC 1991)
7. 10 USC sec 980 8. Doe v Sullivan, 938 F,2d 1370 (DC Cir, 1991)
9. Currie DP. The constitution in the Supreme Courts, the
second century, 1888 to 1986, Chicago, Chicago University Press,
1990, 280-307
10. Keeler JR, Hurst CG, Dunn MA. Pyridostigmine used as a nerve
agent pre-treatment set under wartime conditions. JAMA
1991;266,693-5
11. Waivers for military use of investigational agents. AM Hosp
Pharm 1991;48,1525-9
.
12. Howe EG, Martin ED. Treating the troops, Hastings Cent Rep
1991;2(2) 21-8
13. Treatment of chemical agent casualties and conventional
military chemical injuries; FM 8-285, NAVMED P-5041, AFM 160-11,
Washington DC, Headquarters, Departments of the army, navy and
air force, February 1990;sec 2-15-2-19
14. Johnson WH. Civil rights of military personnel regarding
medical care and experimental procedures. Science 1953;117,212-5
15. United States v Stanley, 483 US 669 (1987)
Top of Page
Current Section Index